Healogics Blog

Established by Healogics in 2014, Wound Care Awareness Week brings attention to the chronic wound epidemic and the nearly 7 million Americans who are currently living with non-healing wounds. Healogics is dedicating the entire week to educating physicians, patients and the general public about the chronic wound epidemic and the advanced wound care solutions available.

Across the United States, there are nearly 7 million people who live with either a chronic wound or one that stubbornly won’t heal. These wounds need proper care, and the longer they go without, the greater the risk of infection, hospitalization and even amputation.

As we celebrate American Heart Month, February is the perfect time for you to focus on your heart health. Various heart conditions such as heart failure, coronary artery disease, cardiomyopathies and high blood pressure/hypertension can make you more likely to get severely ill from COVID-19, according to the U.S. Centers for Disease Control (CDC).

The result has been a surge in amputations across the country.

Healogics mission to advance wound healing includes ongoing research to improve healing rates for patients who entrust us with their care. Our proprietary data, along with analysis of respected medical literature, has revealed four factors that affect patient healing trajectories across all stages of healing. These four factors are: Frequent/Regular Patient Visits, Preventing Stalled Wounds, Increasing Patient Engagement and Utilizing Advanced Modalities. You can read and download all four white papers here. 

By Dr. William Ennis, DO, MBA, MMM, CPE

In our most recent white paper titled, “The Use of Modalities in Wound Care Part 2: Hyperbaric Oxygen Therapy,” we examine the use of Hyperbaric Oxygen Therapy (HBOT) as an adjunctive therapy for diabetic foot ulcers (DFUs) with Wagner grades 3 and 4. We found significantly improved healing rates for Wagner grade 3 and 4 DFUs when the patient was able to complete their entire course of treatment. 

The white paper also examined HBOT for radiation cystitis and notes that the studies to date suggest that patients benefit most from HBOT when they receive treatment early in the course of this disease to maximize the clinical effects of HBOT.